The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 1-10C AML: FLT3 Inhibitors

Fri. Oct 11, 2019 3:20 PM - 4:10 PM No.10 (Tokyo International Forum, 4F G409)

Chair: Yuichi Ishikawa (Department of Hematology, Nagoya University Hospital)

[OS1-10C-3] Safety and tolerability of gilteritinib plus azacitidine in patients with newly diagnosed AML

Goichi Yoshimoto1, Erkut Bahceci2, Elizabeth Shima Rich2, Minoru Kameda3, Ruishan Wu2, Shuichi Miyawaki4, Tomoki Naoe5 (1.Hematology, Oncology and Cardiovascular Medicine, Kyushu Univ, Fukuoka, Japan, 2.Astellas Pharma US, Inc, 3.Astellas Pharma, Inc., Tokyo, Japan, 4.Hematol., Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan, 5.NHO Nagoya Medical Center, Nagoya, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password